As liver cancer rates and mortality continue to rise, advocacy and policy efforts are important

During a session at the 20th Annual Meeting of the International Society of Gastrointestinal Oncology, Sarah Manes, director of the liver cancer program at the Global Liver Institute, highlighted related unmet needs. to liver cancer and discussed the organization’s mission to advance research and address health disparities. Liver cancer is the sixth most common cancer … Read more

Pharmacies compounding Semaglutide raises concerns

Pharmacies compounding Semaglutide raises concerns

The US Food and Drug Administration (FDA) recently warned two online suppliers to stop manufacturing unapproved versions of semaglutide (marketed as Ozempic for type 2 diabetes). 2; Wegovy for obesity) and tirzepatide (Mounjaro). With ongoing shortages of these two popular drugs, compounded versions have become popular. According to the FDA, compounding pharmacies are allowed to … Read more